Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treats severe alopecia areata and is safe.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Upadacitinib may cause hair loss.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

Microemulsions improve adapalene's skin absorption for better acne treatment.

TA-Ado effectively promotes hair growth and reduces hair loss.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Upadacitinib improved multiple immune-related conditions in one patient.

AC5 improves hair loss and hair quality with high satisfaction rates.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

The AAcQLI is a promising tool for assessing quality of life in children with alopecia areata.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Acrodermatitis enteropathica can be linked to dental issues, so thorough dental exams are important.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Classified ads in the Archives of Dermatology offer job listings and opportunities for dermatologists.